BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 2020;318:H1084-90. [PMID: 32228252 DOI: 10.1152/ajpheart.00217.2020] [Cited by in Crossref: 317] [Cited by in F6Publishing: 285] [Article Influence: 158.5] [Reference Citation Analysis]
Number Citing Articles
1 Lima Martínez MM, Contreras MA, Marín W, D’marco L. Statins in COVID-19: Is there any foundation? Clínica e Investigación en Arteriosclerosis (English Edition) 2020;32:278-81. [DOI: 10.1016/j.artere.2020.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight? Med Hypotheses 2020;144:110231. [PMID: 33254538 DOI: 10.1016/j.mehy.2020.110231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
3 Pizarro-Sánchez MS, Avello A, Mas-Fontao S, Stock da Cunha T, Goma-Garcés E, Pereira M, Ortíz A, González-Parra E. Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients. Kidney Blood Press Res 2021;46:126-34. [PMID: 33503627 DOI: 10.1159/000512535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol (1985) 2021;130:877-91. [PMID: 33444117 DOI: 10.1152/japplphysiol.00742.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
5 Cadegiani FA. Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocr Disord 2020;20:149. [PMID: 32993622 DOI: 10.1186/s12902-020-00626-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
6 Alpalhão M, Ferreira JA, Filipe P. Persistent SARS-CoV-2 infection and the risk for cancer. Med Hypotheses 2020;143:109882. [PMID: 32485314 DOI: 10.1016/j.mehy.2020.109882] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
7 Banerjee A, Kanwar M, Santra D, Maiti S. Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike. transl med commun 2022;7. [DOI: 10.1186/s41231-022-00109-5] [Reference Citation Analysis]
8 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Tan CS, Yeoh SF, Long CM. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation. Ann Acad Med Singap 2020;49:398-400. [DOI: 10.47102/annals-acadmedsg.202085] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Suri JS, Puvvula A, Biswas M, Majhail M, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Kolluri R, Teji J, Maini MA, Agbakoba A, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PR, Naidu S. COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review. Comput Biol Med 2020;124:103960. [PMID: 32919186 DOI: 10.1016/j.compbiomed.2020.103960] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
11 Russo V, Silverio A, Scudiero F, Attena E, D'Andrea A, Nunziata L, Parodi G, Celentani D, Varbella F, Albani S, Musumeci G, Di Micco P, Di Maio M. Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study. J Cardiovasc Pharmacol 2021;78:e94-e100. [PMID: 34173802 DOI: 10.1097/FJC.0000000000001041] [Reference Citation Analysis]
12 Jin ZM, Shi JC, Zheng M, Chen QL, Zhou YY, Cheng F, Cai J, Jiang XG. Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19. World J Clin Cases 2022; 10(1): 128-135 [DOI: 10.12998/wjcc.v10.i1.128] [Reference Citation Analysis]
13 Motavalli R, Abdelbasset WK, Rahman HS, Achmad MH, Sergeevna NK, Zekiy AO, Adili A, Khiavi FM, Marofi F, Yousefi M, Ghoreishizadeh S, Shomali N, Etemadi J, Jarahian M. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses. IUBMB Life 2021;73:1005-15. [PMID: 34118117 DOI: 10.1002/iub.2516] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wallentin L, Lindbäck J, Eriksson N, Hijazi Z, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Oldgren J, Siegbahn A. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J 2020;41:4037-46. [PMID: 32984892 DOI: 10.1093/eurheartj/ehaa697] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
15 Mascolo A, Scavone C, Rafaniello C, Ferrajolo C, Racagni G, Berrino L, Paolisso G, Rossi F, Capuano A. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review. Front Cardiovasc Med 2020;7:143. [PMID: 32850989 DOI: 10.3389/fcvm.2020.00143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
16 Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin Investig Arterioscler 2021;33:151-7. [PMID: 33303218 DOI: 10.1016/j.arteri.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
17 Klein SL, Dhakal S, Ursin RL, Deshpande S, Sandberg K, Mauvais-Jarvis F. Biological sex impacts COVID-19 outcomes. PLoS Pathog 2020;16:e1008570. [PMID: 32569293 DOI: 10.1371/journal.ppat.1008570] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 50.0] [Reference Citation Analysis]
18 Altulea D, Maassen S, Baranov MV, van den Bogaart G. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology. J Mol Cell Biol 2021;13:175-84. [PMID: 33693723 DOI: 10.1093/jmcb/mjab016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mascolo A, Scavone C, Rafaniello C, De Angelis A, Urbanek K, di Mauro G, Cappetta D, Berrino L, Rossi F, Capuano A. The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19. Front Pharmacol 2021;12:667254. [PMID: 33959029 DOI: 10.3389/fphar.2021.667254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Drucker DJ. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications. Endocr Rev 2020;41:bnaa011. [PMID: 32294179 DOI: 10.1210/endrev/bnaa011] [Cited by in Crossref: 183] [Cited by in F6Publishing: 159] [Article Influence: 91.5] [Reference Citation Analysis]
21 Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15:e0243191. [PMID: 33284825 DOI: 10.1371/journal.pone.0243191] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
22 Batta Y, King C, Johnson J, Haddad N, Boueri M, Haddad G. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol 2022;12:748972. [DOI: 10.3389/fphys.2021.748972] [Reference Citation Analysis]
23 Hembram P. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021;45:123. [PMID: 34257504 DOI: 10.1186/s42269-021-00582-2] [Reference Citation Analysis]
24 Das SK. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19). Indian J Clin Biochem 2020;:1-12. [PMID: 32837036 DOI: 10.1007/s12291-020-00919-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Gul R, Kim UH, Alfadda AA. Renin-angiotensin system at the interface of COVID-19 infection. Eur J Pharmacol 2021;890:173656. [PMID: 33086029 DOI: 10.1016/j.ejphar.2020.173656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
26 Bodine SC, Morty RE. World Lung Day 2020 at the Journal of Applied Physiology and the American Journal of Physiology-Lung Cellular and Molecular Physiology. Am J Physiol Lung Cell Mol Physiol 2020;319:L534-7. [PMID: 32755315 DOI: 10.1152/ajplung.00371.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Chappell MC, Pirro NT, South AM, Gwathmey TM. Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human Plasma. Hypertension 2021;77:e29-31. [PMID: 33399002 DOI: 10.1161/HYPERTENSIONAHA.120.16724] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
28 Zhong L, Zhu L, Cai ZW. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review. J Anal Test 2021;:1-16. [PMID: 34513131 DOI: 10.1007/s41664-021-00197-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zhao Z, Liu N, Wang C, Cheng J, Guo M. Proteomic analysis of differentially expressed whey proteins in Saanen goat milk from different provinces in China using a data-independent acquisition technique. J Dairy Sci 2021;104:10513-27. [PMID: 34419278 DOI: 10.3168/jds.2020-19877] [Reference Citation Analysis]
30 Perrin EC, South AM. Correlation between kidney sodium and potassium handling and the renin-angiotensin-aldosterone system in children with hypertensive disorders. Pediatr Nephrol 2021. [PMID: 34499251 DOI: 10.1007/s00467-021-05204-7] [Reference Citation Analysis]
31 Kasozi KI, Niedbała G, Alqarni M, Zirintunda G, Ssempijja F, Musinguzi SP, Usman IM, Matama K, Hetta HF, Mbiydzenyuy NE, Batiha GE, Beshbishy AM, Welburn SC. Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections. Front Public Health 2020;8:594458. [PMID: 33363088 DOI: 10.3389/fpubh.2020.594458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
32 Edmonston DL, South AM, Sparks MA, Cohen JB. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System. Adv Chronic Kidney Dis 2020;27:404-11. [PMID: 33308506 DOI: 10.1053/j.ackd.2020.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Adil MS, Verma A, Rudraraju M, Narayanan SP, Somanath PR. Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection. J Cell Physiol 2021;236:6597-606. [PMID: 33624300 DOI: 10.1002/jcp.30343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kohler H, Bäuerle A, Schweda A, Weismüller B, Fink M, Musche V, Robitzsch A, Pfeiffer C, Benecke AV, Dörrie N, Führer D, Taube C, Rassaf T, Teufel M, Skoda EM. Increased COVID-19-related fear and subjective risk perception regarding COVID-19 affects behavior in individuals with internal high-risk diseases. J Prim Care Community Health 2021;12:2150132721996898. [PMID: 33719697 DOI: 10.1177/2150132721996898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Richter D, Guasti L, Koehler F, Squizzato A, Nistri S, Christodorescu R, Dievart F, Gaudio G, Asteggiano R, Ferrini M. Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice. ESC Heart Fail 2021. [PMID: 34170086 DOI: 10.1002/ehf2.13466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 [DOI: 10.1101/2020.05.12.20095885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021;17:1507-20. [PMID: 33907514 DOI: 10.7150/ijbs.59534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Yetmar ZA, Chesdachai S, Kashour T, Riaz M, Gerberi DJ, Badley AD, Berbari EF, Tleyjeh IM. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021;8:ofab284. [PMID: 34258316 DOI: 10.1093/ofid/ofab284] [Reference Citation Analysis]
39 Alirezaei T, Hooshmand S, Irilouzadian R, Hajimoradi B, Montazeri S, Shayegh A. The role of blood urea nitrogen to serum albumin ratio in the prediction of severity and 30‐day mortality in patients with COVID‐19. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.606] [Reference Citation Analysis]
40 Ata F, Montoro-Lopez MN, Awouda S, Elsukkar AMA, Badr AMH, Patel AAAH. COVID-19 and Heart Failure: The Big Challenge. Heart Views. 2020;21:187-192. [PMID: 33688410 DOI: 10.4103/heartviews.heartviews_122_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Rehman SU, Tabish M. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin Sci (Lond) 2020;134:1143-50. [PMID: 32442315 DOI: 10.1042/CS20200419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
42 Rangon CM, Krantic S, Moyse E, Fougère B. The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer's Disease and Aging: A Review of Knowledge. J Alzheimers Dis Rep 2020;4:537-51. [PMID: 33532701 DOI: 10.3233/ADR-200273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, Atif SM, Hariprasad G, Hasan GM, Hassan MI. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis 2020;1866:165878. [PMID: 32544429 DOI: 10.1016/j.bbadis.2020.165878] [Cited by in Crossref: 211] [Cited by in F6Publishing: 186] [Article Influence: 105.5] [Reference Citation Analysis]
44 Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, Chipman JG, Schacker TW, Guirgis FW, Voelker HT, Koopmeiners JS, Tignanelli CJ; Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial. JAMA Netw Open 2022;5:e222735. [PMID: 35294537 DOI: 10.1001/jamanetworkopen.2022.2735] [Reference Citation Analysis]
45 Lala A, Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Januzzi J, Mancini DM, Fuster V. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. medRxiv 2020:2020. [PMID: 32511658 DOI: 10.1101/2020.04.20.20072702] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
46 Marziliano N, Medoro A, Mignogna D, Saccon G, Folzani S, Reverberi C, Russo C, Intrieri M. Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection. Diagnostics (Basel) 2021;11:1229. [PMID: 34359312 DOI: 10.3390/diagnostics11071229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One 2021;16:e0248080. [PMID: 33891615 DOI: 10.1371/journal.pone.0248080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
48 Ferreira JA, Mcmanus J, Jankowski CA, Searcy R. Why the Use of Angiotensin II May be a Fatal Mistake in COVID-19. Shock 2020;54:697-9. [PMID: 32453250 DOI: 10.1097/SHK.0000000000001577] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
50 Aslan S, Eryuruk U. Necrotizing Orchitis due to COVİD-19. Rev Soc Bras Med Trop 2021;54:e04082021. [PMID: 34495259 DOI: 10.1590/0037-8682-0408-2021] [Reference Citation Analysis]
51 Gerstein NS, Venkataramani R, Goumas AM, Chapman NN, Deriy L. COVID-19-Related Cardiovascular Disease and Practical Considerations for Perioperative Clinicians. Semin Cardiothorac Vasc Anesth 2020;24:293-303. [PMID: 32706293 DOI: 10.1177/1089253220943019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Chamata Y, Jackson KG, Watson KA, Jauregi P. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic. Int J Mol Sci 2021;22:11662. [PMID: 34769093 DOI: 10.3390/ijms222111662] [Reference Citation Analysis]
53 Alberca RW, Teixeira FME, Beserra DR, de Oliveira EA, Andrade MMS, Pietrobon AJ, Sato MN. Perspective: The Potential Effects of Naringenin in COVID-19. Front Immunol. 2020;11:570919. [PMID: 33101291 DOI: 10.3389/fimmu.2020.570919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
54 Lu J, Lin J, Yin L, Shi R, Li H, Ge Y, Luo J. Using remote consultation to enhance diagnostic accuracy of bedside transthoracic echocardiography during COVID-19 pandemic. Echocardiography 2021;38:1245-53. [PMID: 34056743 DOI: 10.1111/echo.15124] [Reference Citation Analysis]
55 Yung CS, Fok KCH, Leung CN, Wong YW. What every orthopaedic surgeon should know about COVID-19: A review of the current literature. J Orthop Surg (Hong Kong) 2020;28:230949902092349. [DOI: 10.1177/2309499020923499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
56 El-Anwar MW, Eesa M, Mansour W, Zake LG, Hendawy E. Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients. Int Arch Otorhinolaryngol 2021;25:e343-8. [PMID: 34377166 DOI: 10.1055/s-0041-1730456] [Reference Citation Analysis]
57 [DOI: 10.1101/2020.08.30.274464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Zhang P, Bu Y, Jiang P, Shi X, Lun B, Chen C, Syafiandini AF, Ding Y, Song M. Toward a Coronavirus Knowledge Graph. Genes (Basel) 2021;12:998. [PMID: 34209818 DOI: 10.3390/genes12070998] [Reference Citation Analysis]
59 Bezuidenhout MC, Wiese OJ, Moodley D, Maasdorp E, Davids MR, Koegelenberg CF, Lalla U, Khine-Wamono AA, Zemlin AE, Allwood BW. Correlating arterial blood gas, acid-base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients. Ann Clin Biochem 2021;58:95-101. [PMID: 33103442 DOI: 10.1177/0004563220972539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
60 Lima Martínez MM, Contreras MA, Marín W, D'Marco L. Statins in COVID-19: is there any foundation? Clin Investig Arterioscler 2020;32:278-81. [PMID: 32718669 DOI: 10.1016/j.arteri.2020.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gates LE, Hamed AA. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation. J Med Internet Res 2020;22:e21169. [PMID: 32735546 DOI: 10.2196/21169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
62 Gao F, Zheng KI, Fan YC, Targher G, Byrne CD, Zheng MH. ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis. Am J Gastroenterol. 2020;115:1544. [PMID: 32694292 DOI: 10.14309/ajg.0000000000000780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sfera A, Osorio C, Jafri N, Diaz EL, Campo Maldonado JE. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis. Front Immunol 2020;11:1472. [PMID: 32655579 DOI: 10.3389/fimmu.2020.01472] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
64 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Sandoval J, Del Valle-Mondragón L, Masso F, Zayas N, Pulido T, Teijeiro R, Gonzalez-Pacheco H, Olmedo-Ocampo R, Sisniega C, Paez-Arenas A, Pastelin-Hernandez G, Gomez-Arroyo J, Voelkel NF. Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension. Eur Respir J 2020;56:1902416. [PMID: 32241831 DOI: 10.1183/13993003.02416-2019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
66 Oussalah A, Gleye S, Clerc Urmes I, Laugel E, Callet J, Barbé F, Orlowski S, Malaplate C, Aimone-Gastin I, Caillierez BM, Merten M, Jeannesson E, Kormann R, Olivier JL, Rodriguez-Guéant RM, Namour F, Bevilacqua S, Losser MR, Levy B, Kimmoun A, Gibot S, Thilly N, Frimat L, Schvoerer E, Guéant JL. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France. Clin Infect Dis 2020;71:2447-56. [PMID: 32623470 DOI: 10.1093/cid/ciaa677] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
67 Cadegiani FA, Goren A, Wambier CG. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses 2020;143:110112. [PMID: 32721806 DOI: 10.1016/j.mehy.2020.110112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
68 Paniri A, Hosseini MM, Moballegh-Eslam M, Akhavan-Niaki H. Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations. Gene Rep 2021;22:100979. [PMID: 33294728 DOI: 10.1016/j.genrep.2020.100979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
69 [DOI: 10.1101/2020.05.12.20098160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Sadhukhan P, Ugurlu MT, Hoque MO. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes. Cancers (Basel) 2020;12:E3822. [PMID: 33352869 DOI: 10.3390/cancers12123822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
71 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
72 Henry BM, Benoit S, Lippi G, Benoit J. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report. Prog Cardiovasc Dis 2020;63:702-3. [PMID: 32659343 DOI: 10.1016/j.pcad.2020.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
73 Nunn AVW, Guy GW, Brysch W, Botchway SW, Frasch W, Calabrese EJ, Bell JD. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing. Immun Ageing 2020;17:33. [PMID: 33292333 DOI: 10.1186/s12979-020-00204-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
74 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost 2020;120:1629-41. [PMID: 33124029 DOI: 10.1055/s-0040-1718735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
75 Liu P, Xie X, Gao L, Jin J. Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects. Int J Biol Macromol 2020;165:1626-33. [PMID: 33080267 DOI: 10.1016/j.ijbiomac.2020.10.120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
76 Magnocavallo M, Vetta G, Della Rocca DG, Gianni C, Mohanty S, Bassiouny M, Di Lullo L, Del Prete A, Cirone D, Lavalle C, Chimenti C, Al-ahmad A, Burkhardt JD, Gallinghouse GJ, Sanchez JE, Horton RP, Di Biase L, Natale A. Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients. Cardiac Electrophysiology Clinics 2022. [DOI: 10.1016/j.ccep.2021.10.001] [Reference Citation Analysis]
77 Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2-13. [PMID: 33229199 DOI: 10.1016/j.numecd.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Saavedra LPJ, Prates KV, Gonçalves GD, Piovan S, Matafome P, Mathias PCF. COVID-19 During Development: A Matter of Concern. Front Cell Dev Biol 2021;9:659032. [PMID: 33898461 DOI: 10.3389/fcell.2021.659032] [Reference Citation Analysis]
79 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Reference Citation Analysis]
80 Mohit, Shrivastava A, Dutt P, Singh MK, Chand P. COVID-19 exposure and obstructive sleep apnea: a therapeutic approach. Sleep Med 2021;81:123. [PMID: 33667997 DOI: 10.1016/j.sleep.2021.02.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Shirazi FM, Banerji S, Nakhaee S, Mehrpour O. Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view. Eur J Clin Microbiol Infect Dis 2020;39:2001-2. [PMID: 32557325 DOI: 10.1007/s10096-020-03932-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Karmouty-Quintana H, Thandavarayan RA, Keller SP, Sahay S, Pandit LM, Akkanti B. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Int J Mol Sci 2020;21:E8081. [PMID: 33138181 DOI: 10.3390/ijms21218081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
83 Yim J, Lim HH, Kwon Y. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development. Arch Pharm Res 2021;44:499-513. [PMID: 34047940 DOI: 10.1007/s12272-021-01331-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Pola A, Murthy KS, Santhekadur PK. COVID-19 and gastrointestinal system: A brief review. Biomed J 2021;44:245-51. [PMID: 34130944 DOI: 10.1016/j.bj.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
86 Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957-966. [PMID: 32412156 DOI: 10.1002/ejhf.1871] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 42.0] [Reference Citation Analysis]
87 Morty RE, Ziebuhr J. Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection. Am J Physiol Lung Cell Mol Physiol 2020;318:L1016-9. [PMID: 32266822 DOI: 10.1152/ajplung.00136.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
88 Sun H, Guo P, Zhang L, Wang F. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020. Med Sci Monit 2020;26:e926941. [PMID: 33175722 DOI: 10.12659/MSM.926941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
89 Files DC, Gibbs KW, Schaich CL, Collins SP, Gwathmey TM, Casey JD, Self WH, Chappell MC. A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure. Am J Physiol Lung Cell Mol Physiol 2021;321:L213-8. [PMID: 34009036 DOI: 10.1152/ajplung.00129.2021] [Reference Citation Analysis]
90 Yokota S, Miyamae T, Kuroiwa Y, Nishioka K. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology. J Clin Med 2021;10:801. [PMID: 33671159 DOI: 10.3390/jcm10040801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
91 Migliaccio MG, Di Mauro M, Ricciolino R, Spiniello G, Carfora V, Verde N, Mottola FF, Coppola N; Vanvitelli COVID-19 Group. Renal Involvement in COVID-19: A Review of the Literature. Infect Drug Resist 2021;14:895-903. [PMID: 33707958 DOI: 10.2147/IDR.S288869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Reference Citation Analysis]
93 Polak Y, Speth RC. Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity. Peptides 2021;137:170477. [PMID: 33400951 DOI: 10.1016/j.peptides.2020.170477] [Reference Citation Analysis]
94 Elrashdy F, Redwan EM, Uversky VN. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Infect Genet Evol 2020;85:104510. [PMID: 32853823 DOI: 10.1016/j.meegid.2020.104510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
95 Cohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AM. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. J Hypertens 2021;39:795-805. [PMID: 33186321 DOI: 10.1097/HJH.0000000000002706] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
96 Orlowski S, Mourad JJ, Gallo A, Bruckert E. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19. Biochimie 2021;189:51-64. [PMID: 34153377 DOI: 10.1016/j.biochi.2021.06.005] [Reference Citation Analysis]
97 Datta PK, Liu F, Fischer T, Rappaport J, Qin X. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics 2020;10:7448-64. [PMID: 32642005 DOI: 10.7150/thno.48076] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 30.0] [Reference Citation Analysis]
98 Santra D, Banerjee A, Maiti S. Better binding informatics of delta variants (B.1.617.2) with ACE2 than wild, D614G or N501Y CoV-2 is fully blocked by 84 amino-acid cut of wild spike. Informatics in Medicine Unlocked 2022;29:100900. [DOI: 10.1016/j.imu.2022.100900] [Reference Citation Analysis]
99 Cadegiani FA, Wambier CG, Goren A. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Front Med (Lausanne) 2020;7:453. [PMID: 32850920 DOI: 10.3389/fmed.2020.00453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
100 Liu D, Ding HL, Chen Y, Chen DH, Yang C, Yang LM, Liu JA, Zhang L, Xia ZY, Zhang XH, Lei S, Xia Z. Comparison of the clinical characteristics and mortalities of severe COVID-19 patients between pre- and post-menopause women and age-matched men. Aging (Albany NY) 2021;13:21903-13. [PMID: 34551393 DOI: 10.18632/aging.203532] [Reference Citation Analysis]
101 Umeoguaju FU, Ephraim-Emmanuel BC, Uba JO, Bekibele GE, Chigozie N, Orisakwe OE. Immunomodulatory and Mechanistic Considerations of Hibiscus sabdariffa (HS) in Dysfunctional Immune Responses: A Systematic Review. Front Immunol 2021;12:550670. [PMID: 34040600 DOI: 10.3389/fimmu.2021.550670] [Reference Citation Analysis]
102 Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, Vassilikos V, Stellos K. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol 2020;61:381-95. [PMID: 32534109 DOI: 10.1016/j.hjc.2020.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
103 Klhůfek J. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero? Acta Clinica Belgica. [DOI: 10.1080/17843286.2020.1786324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
104 Schnaubelt S, Breyer MK, Siller-Matula J, Domanovits H. Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33089045 DOI: 10.1093/ehjcr/ytaa166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
105 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Pavlov V, Beylerli O, Gareev I, Torres Solis LF, Solís Herrera A, Aliev G. COVID-19-Related Intracerebral Hemorrhage. Front Aging Neurosci 2020;12:600172. [PMID: 33192492 DOI: 10.3389/fnagi.2020.600172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
107 Revercomb L, Hanmandlu A, Wareing N, Akkanti B, Karmouty-Quintana H. Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS). Front Mol Biosci 2020;7:624093. [PMID: 33537342 DOI: 10.3389/fmolb.2020.624093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
108 Kaseb AO, Mohamed YI, Malek AE, Raad II, Altameemi L, Li D, Kaseb OA, Kaseb SA, Selim A, Ma Q. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens 2021;10:379. [PMID: 33809851 DOI: 10.3390/pathogens10030379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Prestes PR, Maier MC, Woods BA, Charchar FJ. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease. Int J Mol Sci 2020;21:E3666. [PMID: 32455975 DOI: 10.3390/ijms21103666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
110 Bach I, Surathi P, Montealegre N, Abu-Hadid O, Rubenstein S, Redko S, Gupta S, Hillen M, Patel P, Khandelwal P, Kamel A. Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic. Stroke Vasc Neurol 2020;5:331-6. [PMID: 32973116 DOI: 10.1136/svn-2020-000525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
111 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Deng YP, Xie W, Liu T, Wang SY, Wang MR, Zan YX, Meng XB, Deng YQ, Xiong HR, Fu XD. Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A Single-centered, Retrospective Study. Arq Bras Cardiol 2021:S0066-782X2021005010205. [PMID: 34287571 DOI: 10.36660/abc.20200733] [Reference Citation Analysis]
113 Del Rio R, Marcus NJ, Inestrosa NC. Potential Role of Autonomic Dysfunction in Covid-19 Morbidity and Mortality. Front Physiol 2020;11:561749. [PMID: 33178034 DOI: 10.3389/fphys.2020.561749] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
114 Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
115 Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". Circ Res 2020;126:e140-1. [PMID: 32496917 DOI: 10.1161/CIRCRESAHA.120.317205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
116 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Han K, Blair RV, Iwanaga N, Liu F, Russell-Lodrigue KE, Qin Z, Midkiff CC, Golden NA, Doyle-Meyers LA, Kabir ME, Chandler KE, Cutrera KL, Ren M, Monjure CJ, Lehmicke G, Fischer T, Beddingfield B, Wanek AG, Birnbaum A, Maness NJ, Roy CJ, Datta PK, Rappaport J, Kolls JK, Qin X. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Am J Respir Cell Mol Biol. 2021;64:79-88. [PMID: 32991819 DOI: 10.1165/rcmb.2020-0354oc] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
118 Sandhu AT, Kohsaka S, Lin S, Woo CY, Goldstein MK, Heidenreich PA. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system. Am Heart J 2021;240:46-57. [PMID: 34126079 DOI: 10.1016/j.ahj.2021.06.004] [Reference Citation Analysis]
119 Elfiky AA, Ibrahim IM, Amin FG, Ismail AM, Elshemey WM. COVID-19 and Cell Stress. Adv Exp Med Biol 2021;1318:169-78. [PMID: 33973178 DOI: 10.1007/978-3-030-63761-3_10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Li Q, Grant MB, Richards EM, Raizada MK. ACE2 as therapeutic agent. Clin Sci (Lond) 2020;134:2581-95. [PMID: 33063820 DOI: 10.1042/CS20200570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
121 Olaleye OA, Kaur M, Onyenaka C, Adebusuyi T. Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro. bioRxiv 2020:2020. [PMID: 32817951 DOI: 10.1101/2020.08.14.250480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
122 Pfeifer M, Ewig S, Voshaar T, Randerath WJ, Bauer T, Geiseler J, Dellweg D, Westhoff M, Windisch W, Schönhofer B, Kluge S, Lepper PM. Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19. Respiration 2020;99:521-42. [PMID: 32564028 DOI: 10.1159/000509104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
123 Banach M, Penson PE, Fras Z, Vrablik M, Pella D, Reiner Ž, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M; FH Europe and the International Lipid Expert Panel (ILEP). Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacol Res 2020;158:104891. [PMID: 32389859 DOI: 10.1016/j.phrs.2020.104891] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
124 Singh J, Bhagaloo L, Sy E, Lavoie AJ, Dehghani P, Neary P. Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies. Physiol Rep 2021;9:e14998. [PMID: 34448551 DOI: 10.14814/phy2.14998] [Reference Citation Analysis]
125 Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, Guignabert C, Humbert M. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020;56:2001634. [PMID: 32554538 DOI: 10.1183/13993003.01634-2020] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 54.0] [Reference Citation Analysis]
126 Wiesner O, Busch M, David S. [Treatment of severe COVID-19 courses in intensive care medicine]. Internist (Berl) 2020;61:804-12. [PMID: 32710161 DOI: 10.1007/s00108-020-00850-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
127 Fabregues F, Peñarrubia J. Assisted reproduction and thromboembolic risk in the COVID-19 pandemic. Reprod Biomed Online 2020;41:361-4. [PMID: 32660814 DOI: 10.1016/j.rbmo.2020.06.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Nourinia R, Ghassempour M, Ahmadieh H, Abtahi SH. Branch retinal vein occlusion after COVID-19. J Fr Ophtalmol 2021:S0181-5512(21)00350-8. [PMID: 34325925 DOI: 10.1016/j.jfo.2021.06.003] [Reference Citation Analysis]
129 Yu H, Li C, Wang X, Duan J, Yang N, Xie L, Yuan Y, Li S, Bi C, Yang B, Li Y. Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic. J Proteome Res 2020;19:4242-58. [PMID: 32957788 DOI: 10.1021/acs.jproteome.0c00372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
130 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
131 Zhao S, Huang Z, Zeng H, Chen Z, Luo F, Zhang C, Song B. Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia. Sci Rep 2021;11:6422. [PMID: 33742041 DOI: 10.1038/s41598-021-85779-1] [Reference Citation Analysis]
132 Soltani P, Baghaei K, Tavakoli Tafti K, Spagnuolo G. Science Mapping Analysis of COVID-19 Articles Published in Dental Journals. Int J Environ Res Public Health 2021;18:2110. [PMID: 33671518 DOI: 10.3390/ijerph18042110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
133 Zhang Q, Li J, Zhang Y, Gao J, Wang P, Ai M, Ding W, Tan X. Differences in clinical characteristics and liver injury between suspected and confirmed COVID-19 patients in Jingzhou, Hubei Province of China. Medicine (Baltimore) 2021;100:e25913. [PMID: 34106656 DOI: 10.1097/MD.0000000000025913] [Reference Citation Analysis]
134 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
135 Kumar S, Zhi K, Mukherji A, Gerth K. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19. Viruses 2020;12:E486. [PMID: 32357553 DOI: 10.3390/v12050486] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
136 Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ 2020;29:973-87. [PMID: 32601020 DOI: 10.1016/j.hlc.2020.05.101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
137 Paital B, Agrawal PK. Air pollution by NO2 and PM2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in respiratory cells: a review. Environ Chem Lett 2020;:1-18. [PMID: 32982622 DOI: 10.1007/s10311-020-01091-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
138 Hafiane A. SARS-CoV-2 and the cardiovascular system. Clin Chim Acta 2020;510:311-6. [PMID: 32681935 DOI: 10.1016/j.cca.2020.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
139 Wu H, Huang C, Daga KR, Marklein RA, Ivanova N, Zeltner N. Human pluripotent stem cell-derived functional sympathetic neurons express ACE2 and RAAS components: a framework for studying the effect of COVID-19 on sympathetic responsiveness. Clin Auton Res. [DOI: 10.1007/s10286-021-00850-1] [Reference Citation Analysis]
140 Dupont V, Kanagaratnam L, Goury A, Poitevin G, Bard M, Julien G, Bonnivard M, Champenois V, Noel V, Mourvillier B, Nguyen P. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients. Clin Infect Dis 2021;72:1834-7. [PMID: 32672790 DOI: 10.1093/cid/ciaa1007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
141 Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021;27:89-95. [PMID: 32979574 DOI: 10.1016/j.cmi.2020.09.023] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 39.0] [Reference Citation Analysis]
142 Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther 2021;6:396. [PMID: 34782609 DOI: 10.1038/s41392-021-00809-8] [Reference Citation Analysis]
143 Cadegiani FA. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? Am J Physiol Endocrinol Metab 2020;318:E587-8. [PMID: 32297520 DOI: 10.1152/ajpendo.00136.2020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
144 Sheng HW, Wang HG, Wang CZ, Wu J, Huo LJ, Wang RX, Zhou YJ, Zhang XY. Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China. World J Psychiatry 2022; 12(1): 140-150 [DOI: 10.5498/wjp.v12.i1.140] [Reference Citation Analysis]
145 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
146 Fedson DS. COVID-19, host response treatment, and the need for political leadership. J Public Health Policy 2021;42:6-14. [PMID: 33268844 DOI: 10.1057/s41271-020-00266-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Westhoff M, Geiseler J, Schönhofer B, Pfeifer M, Dellweg D, Bachmann M, Randerath W. [Weaning in a Pandemic Situation - A Position Paper]. Pneumologie 2021;75:113-21. [PMID: 33352589 DOI: 10.1055/a-1337-9848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Hypertension 2020;76:1339-49. [PMID: 32851855 DOI: 10.1161/HYPERTENSIONAHA.120.15256] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 25.5] [Reference Citation Analysis]
149 Hu S, Wang J, Zhang Y, Bai H, Wang C, Wang N, He L. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2. J Med Virol 2021;93:3143-51. [PMID: 33580518 DOI: 10.1002/jmv.26874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
150 Zemlin AE, Wiese OJ. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2). Ann Clin Biochem 2020;57:339-50. [PMID: 32369402 DOI: 10.1177/0004563220928361] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
151 Dawson D, Dominic P, Sheth A, Modi M. Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis. Res Sq 2020:rs. [PMID: 32702736 DOI: 10.21203/rs.3.rs-34729/v1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
152 Cai L, Guo X, Cao Y, Ying P, Hong L, Zhang Y, Yi G, Fu M. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review). Int J Mol Med 2021;47:43. [PMID: 33576441 DOI: 10.3892/ijmm.2021.4876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
154 Aralova NI; V. M. Glushkov Institute of Cybernetics of National Academy of Sciences of Ukraine, Kyiv. MATHEMATICAL MODEL FOR THE INVESTIGATION OF HYPOXIC STATES IN THE HEART MUSCLE AT VIRAL DAMAGE. Biotechnol acta 2021;14:38-52. [DOI: 10.15407/biotech14.04.038] [Reference Citation Analysis]
155 Krishnamurthy S, Lockey RF, Kolliputi N. Soluble ACE2 as a potential therapy for COVID-19. Am J Physiol Cell Physiol 2021;320:C279-81. [PMID: 33502950 DOI: 10.1152/ajpcell.00478.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
156 Shao X, Zhang X, Zhang R, Zhu R, Hou X, Yi W, Wu F, Hao L, Feng R. The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart injured patients infected with SARS-CoV-2. Am J Physiol Cell Physiol 2022. [PMID: 35138176 DOI: 10.1152/ajpcell.00169.2021] [Reference Citation Analysis]
157 Dey A, Sen S, Maulik U. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade. Brief Bioinform. 2020;. [PMID: 32968798 DOI: 10.1093/bib/bbaa214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
158 Sang CJ 3rd, Heindl B, Von Mering G, Brott B, Kopf RS, Rajapreyar I. ST Elevations in the Era of COVID-19. Case Rep Cardiol 2020;2020:8845627. [PMID: 32855827 DOI: 10.1155/2020/8845627] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Chan VW, Chiu PK, Yee CH, Yuan Y, Ng CF, Teoh JY. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J Urol. 2020;. [PMID: 32462305 DOI: 10.1007/s00345-020-03246-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
160 Yalcin HC, Sukumaran V, Al-Ruweidi MKAA, Shurbaji S. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms. Int J Mol Sci 2021;22:6703. [PMID: 34201415 DOI: 10.3390/ijms22136703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther 2020;215:107628. [PMID: 32653530 DOI: 10.1016/j.pharmthera.2020.107628] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
162 Yue-liang X, Jiang-lin W, Hui-qin Y, Ge Z, Hongyu D, Wei-jin F, Xiao-cong Z. The risk factors for severe patients with COVID-19 in China: A systematic review and meta-analysis. Eur J Inflamm 2021;19:205873922110008. [DOI: 10.1177/20587392211000890] [Reference Citation Analysis]
163 Viveiros A, Rasmuson J, Vu J, Mulvagh SL, Yip CYY, Norris CM, Oudit GY. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Am J Physiol Heart Circ Physiol 2021;320:H296-304. [PMID: 33275517 DOI: 10.1152/ajpheart.00755.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
164 Sheikhzadeh Hesari F, Hosseinzadeh SS, Asl Monadi Sardroud MA. Review of COVID-19 and male genital tract. Andrologia 2021;53:e13914. [PMID: 33236375 DOI: 10.1111/and.13914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
165 Olaleye OA, Kaur M, Onyenaka C, Adebusuyi T. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro. Heliyon 2021;7:e06426. [PMID: 33732940 DOI: 10.1016/j.heliyon.2021.e06426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
166 Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-84. [PMID: 32750108 DOI: 10.1093/cvr/cvaa230] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 44.5] [Reference Citation Analysis]
167 Chiner-vives E, Cordovilla-pérez R, Rosa-carrillo DDL, García-clemente M, Izquierdo-alonso JL, Otero-candelera R, Llano LP, Sellares-torres J, Granda-orive JID. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2022.03.011] [Reference Citation Analysis]
168 Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V; Mount Sinai COVID Informatics Center. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol 2020;76:533-46. [PMID: 32517963 DOI: 10.1016/j.jacc.2020.06.007] [Cited by in Crossref: 211] [Cited by in F6Publishing: 228] [Article Influence: 105.5] [Reference Citation Analysis]
169 A Elrayess M, T Zedan H, A Alattar R, Abusriwil H, Al-Ruweidi MKAA, Almuraikhy S, Parengal J, Alhariri B, Yassine HM, A Hssain A, Nair A, Al Samawi M, Abdelmajid A, Al Suwaidi J, Omar Saad M, Al-Maslamani M, Omrani AS, Yalcin HC. Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs. Blood Press 2022;31:80-90. [PMID: 35548940 DOI: 10.1080/08037051.2022.2055530] [Reference Citation Analysis]
170 Shovlin CL, Vizcaychipi MP. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster. QJM 2020:hcaa241. [PMID: 32777054 DOI: 10.1093/qjmed/hcaa241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Rego Lorca D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, Burgos-Blasco B, Donate Lopez J. Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19. Acta Ophthalmol 2020. [PMID: 33354904 DOI: 10.1111/aos.14718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Tadic M, Cuspidi C, Grassi G, Mancia G. COVID-19 and arterial hypertension: Hypothesis or evidence? J Clin Hypertens (Greenwich) 2020;22:1120-6. [PMID: 32627330 DOI: 10.1111/jch.13925] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
173 Akhtar S, Benter IF, Danjuma MI, Doi SAR, Hasan SS, Habib AM. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target 2020;28:683-99. [PMID: 32700580 DOI: 10.1080/1061186X.2020.1797754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
174 Brazão SC, Autran LJ, Lopes RDO, Scaramello CBV, Brito FCFD, Motta NAV. Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Pan Y, Gao F, Zhao S, Han J, Chen F. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection. Clin Exp Pharmacol Physiol 2021;48:637-50. [PMID: 33565127 DOI: 10.1111/1440-1681.13483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Blasco H, Bessy C, Plantier L, Lefevre A, Piver E, Bernard L, Marlet J, Stefic K, Benz-de Bretagne I, Cannet P, Lumbu H, Morel T, Boulard P, Andres CR, Vourc'h P, Hérault O, Guillon A, Emond P. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci Rep 2020;10:16824. [PMID: 33033346 DOI: 10.1038/s41598-020-73966-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
177 Aggarwal A, Cohen E, Figueira M, Sabharwal V, Herlihy JM, Bronwen C, Barnett ED, Pelton SI, Camelo IY. Multisystem Inflammatory Syndrome in an Adult With COVID-19-A Trial of Anakinra: A Case Report. Infect Dis Clin Pract (Baltim Md) 2021;29:e420-3. [PMID: 34803350 DOI: 10.1097/IPC.0000000000001028] [Reference Citation Analysis]
178 Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020;313:126-36. [PMID: 33045618 DOI: 10.1016/j.atherosclerosis.2020.09.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
179 Welling PA, Batlle D, Byrd JB, Burrell LM, South AM, Sparks MA. Rigor before speculation in COVID-19 therapy. Am J Physiol Lung Cell Mol Physiol 2020;318:L1027-8. [PMID: 32364442 DOI: 10.1152/ajplung.00152.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Baryah ANS, Midha V, Mahajan R, Sood A. Impact of Corona Virus Disease-19 (COVID-19) pandemic on gastrointestinal disorders. Indian J Gastroenterol 2020;39:214-9. [PMID: 32749642 DOI: 10.1007/s12664-020-01071-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
181 Hallaj S, Ghorbani A, Mousavi-Aghdas SA, Mirza-Aghazadeh-Attari M, Sevbitov A, Hashemi V, Hallaj T, Jadidi-Niaragh F. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2. Immunol Cell Biol 2021;99:192-205. [PMID: 32864784 DOI: 10.1111/imcb.12396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Lee WH, Chen YC, Chen SC, Chen CJ, Hsu PC, Tsai WC, Chu CY, Lee CS, Lin TH, Voon WC, Kuo CH, Su HM. Cardiovascular disease management during the coronavirus disease 2019 pandemic. Int J Med Sci 2020;17:1340-4. [PMID: 32624690 DOI: 10.7150/ijms.46484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Gorini F, Chatzianagnostou K, Mazzone A, Bustaffa E, Esposito A, Berti S, Bianchi F, Vassalle C. "Acute Myocardial Infarction in the Time of COVID-19": A Review of Biological, Environmental, and Psychosocial Contributors. Int J Environ Res Public Health 2020;17:E7371. [PMID: 33050220 DOI: 10.3390/ijerph17207371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Hakami A, Moafa A, Alomaish A, Mashraqi M. Bradyarrhythmia in COVID-19 Patients. Cureus 2021;13:e19367. [PMID: 34925977 DOI: 10.7759/cureus.19367] [Reference Citation Analysis]
185 Li Q, Huang XT, Li CH, Liu D, Lv FJ. CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern. Eur J Radiol 2021;134:109442. [PMID: 33321459 DOI: 10.1016/j.ejrad.2020.109442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
186 Ediz C, Tavukcu HH, Akan S, Kizilkan YE, Alcin A, Oz K, Yilmaz O. Is there any association of COVID-19 with testicular pain and epididymo-orchitis? Int J Clin Pract 2021;75:e13753. [PMID: 33063899 DOI: 10.1111/ijcp.13753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
187 Bhati S, Kaushik V, Singh J. Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19. J Mol Struct 2021;1237:130380. [PMID: 33840835 DOI: 10.1016/j.molstruc.2021.130380] [Reference Citation Analysis]
188 Li P, Wu W, Zhang T, Wang Z, Li J, Zhu M, Liang Y, You W, Li K, Ding R, Huang B, Wu L, Duan W, Han Y, Li X, Tang X, Wang X, Shen H, Wang Q, Yan H, Xia X, Ji Y, Chen H. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care 2021;25:158. [PMID: 33902676 DOI: 10.1186/s13054-021-03555-z] [Reference Citation Analysis]
189 Naidu V, Zeki AA, Sharma P. Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID-19. J Investig Med 2021;69:954-61. [PMID: 33926967 DOI: 10.1136/jim-2020-001768] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
190 Almutairi MM, Sivandzade F, Albekairi TH, Alqahtani F, Cucullo L. Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front Med (Lausanne) 2021;8:745789. [PMID: 34901061 DOI: 10.3389/fmed.2021.745789] [Reference Citation Analysis]
191 Bendjelid K. Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock? Crit Care 2020;24:407. [PMID: 32646518 DOI: 10.1186/s13054-020-03144-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
192 Manolis AS, Manolis TA, Manolis AA, Melita H. The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection. J Cardiovasc Pharmacol 2020;76:397-406. [PMID: 32769760 DOI: 10.1097/FJC.0000000000000894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
193 Zdanyte M, Rath D. Cardiovascular Risk Assessment in COVID-19. Hamostaseologie 2021. [PMID: 34380170 DOI: 10.1055/a-1539-8711] [Reference Citation Analysis]
194 . Primer on the Pathogenesis of Severe COVID-19: Part Two. EMJ. [DOI: 10.33590/emj/20-00159] [Reference Citation Analysis]
195 Jiang X, Li H, Liu Y, Bao L, Zhan L, Gao H, Deng W, Xue J, Liu J, Liu X, Li J, Wang J, Wu S, Yan M, Luo W, Jose PA, Qin C, Yang X, Zhang D, Yang Z. The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice. J Cardiovasc Transl Res 2022. [PMID: 34973134 DOI: 10.1007/s12265-021-10147-3] [Reference Citation Analysis]
196 Yetmar ZA, Challener DW, Tleyjeh IM, Sohail MR, Cerhan JR, Badley AD, O'Horo JC. Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19. Mayo Clin Proc Innov Qual Outcomes 2021;5:442-6. [PMID: 33748678 DOI: 10.1016/j.mayocpiqo.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
197 Menon R, Otto EA, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana AS, Luo J, Yang Y, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Harder JL, Mariani LH, Hodgin JB, Sexton JZ, Wobus CE, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease. Kidney Int 2020;98:1502-18. [PMID: 33038424 DOI: 10.1016/j.kint.2020.09.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
198 Paltrinieri S, Giordano A, Stranieri A, Lauzi S. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar? Transbound Emerg Dis 2021;68:1786-99. [PMID: 32985113 DOI: 10.1111/tbed.13856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
199 Dolan ME, Hill DP, Mukherjee G, McAndrews MS, Chesler EJ, Blake JA. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease. Sci Rep 2020;10:20848. [PMID: 33257774 DOI: 10.1038/s41598-020-77632-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
200 Nikiforuk AM, Kuchinski KS, Twa DDW, Lukac CD, Sbihi H, Basham CA, Steidl C, Prystajecky NA, Jassem AN, Krajden M, Patrick DM, Sekirov I. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. EBioMedicine 2021;66:103316. [PMID: 33819740 DOI: 10.1016/j.ebiom.2021.103316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
201 South AM, Brady TM, Flynn JT. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective. Hypertension 2020;76:16-22. [PMID: 32367746 DOI: 10.1161/HYPERTENSIONAHA.120.15291] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 24.5] [Reference Citation Analysis]
202 Bendjelid K, Muller L. Haemodynamic monitoring of COVID-19 patients: Classical methods and new paradigms. Anaesth Crit Care Pain Med 2020;39:551-2. [PMID: 32896671 DOI: 10.1016/j.accpm.2020.09.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 O'Connor DB, Aggleton JP, Chakrabarti B, Cooper CL, Creswell C, Dunsmuir S, Fiske ST, Gathercole S, Gough B, Ireland JL, Jones MV, Jowett A, Kagan C, Karanika-Murray M, Kaye LK, Kumari V, Lewandowsky S, Lightman S, Malpass D, Meins E, Morgan BP, Morrison Coulthard LJ, Reicher SD, Schacter DL, Sherman SM, Simms V, Williams A, Wykes T, Armitage CJ. Research priorities for the COVID-19 pandemic and beyond: A call to action for psychological science. Br J Psychol 2020;111:603-29. [PMID: 32683689 DOI: 10.1111/bjop.12468] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
204 Bouazza B, Hadj-Said D, Pescatore KA, Chahed R. Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19? Tuberc Respir Dis (Seoul) 2021;84:22-34. [PMID: 33099990 DOI: 10.4046/trd.2020.0101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Pérez-Bermejo M, Peris-Ochando B, Murillo-Llorente MT. COVID-19: Relationship and Impact on Breastfeeding-A Systematic Review. Nutrients 2021;13:2972. [PMID: 34578848 DOI: 10.3390/nu13092972] [Reference Citation Analysis]
206 Ma Z, Li X, Fan RLY, Yang KY, Ng CSH, Lau RWH, Wong RHL, Ng KK, Wang CC, Ye P, Fu Z, Chin AWH, Lai MYA, Huang Y, Tian XY, Poon LLM, Lui KO. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports 2022:S2213-6711(22)00059-5. [PMID: 35180397 DOI: 10.1016/j.stemcr.2022.01.015] [Reference Citation Analysis]
207 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
208 [DOI: 10.1101/2020.06.03.20120261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
209 Zhu F, Li W, Lin Q, Xu M, Du J, Li H. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Med Clin (Barc) 2021;157:164-71. [PMID: 33958143 DOI: 10.1016/j.medcli.2021.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
210 Karim MM, Sultana S, Sultana R, Rahman MT. Possible Benefits of Zinc supplement in CVD and COVID-19 Comorbidity. J Infect Public Health 2021;14:1686-92. [PMID: 34649043 DOI: 10.1016/j.jiph.2021.09.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Lee SA, Park R, Yang JH, Min IK, Park JT, Han SH, Kang SW, Yoo TH. Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis. Sci Rep 2021;11:13588. [PMID: 34193877 DOI: 10.1038/s41598-021-92323-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Paredes-ramos M, Conde Piñeiro E, Pérez-sánchez H, López-vilariño JM, Alu'datt MH. Evaluation of Natural Peptides to Prevent and Reduce the Novel SARS-CoV-2 Infection. Journal of Food Quality 2022;2022:1-13. [DOI: 10.1155/2022/2102937] [Reference Citation Analysis]
213 Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med 2021;46:382-91. [PMID: 33268238 DOI: 10.1016/j.ajem.2020.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 13.5] [Reference Citation Analysis]
214 Reyes-Alcaraz A, Lucero Garcia-Rojas EY, Merlinsky EA, Seong JY, Bond RA, McConnell BK. A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development. Commun Biol 2022;5:212. [PMID: 35260793 DOI: 10.1038/s42003-022-03163-9] [Reference Citation Analysis]
215 Vahabi N, Salehi M, Duarte JD, Mollalo A, Michailidis G. County-level longitudinal clustering of COVID-19 mortality to incidence ratio in the United States. Sci Rep 2021;11:3088. [PMID: 33542313 DOI: 10.1038/s41598-021-82384-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
216 Okpechi SC, Fong JT, Gill SS, Harman JC, Nguyen TH, Chukwurah QC, Onor IO, Alahari SK. Global Sex Disparity of COVID-19: A Descriptive Review of Sex Hormones and Consideration for the Potential Therapeutic Use of Hormone Replacement Therapy in Older Adults. Aging Dis 2021;12:671-83. [PMID: 33815890 DOI: 10.14336/AD.2020.1211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
217 Moro E, Priori A, Beghi E, Helbok R, Campiglio L, Bassetti CL, Bianchi E, Maia LF, Ozturk S, Cavallieri F, Zedde M, Sellner J, Bereczki D, Rakusa M, Di Liberto G, Sauerbier A, Pisani A, Macerollo A, Soffietti R, Taba P, Crean M, Twardzik A, Oreja-Guevara C, Bodini B, Jenkins TM, von Oertzen TJ; EAN core COVID-19 Task Force. The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol 2020;27:1727-37. [PMID: 32558002 DOI: 10.1111/ene.14407] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 21.5] [Reference Citation Analysis]
218 Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Adv Ther 2020;37:3450-62. [PMID: 32632851 DOI: 10.1007/s12325-020-01417-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
219 Çakır B, Okuyan B, Şener G, Tunali-Akbay T. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis. Eur J Pharmacol 2021;891:173781. [PMID: 33271151 DOI: 10.1016/j.ejphar.2020.173781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
220 Saavedra JM. COVID-19, Angiotensin Receptor Blockers, and the Brain. Cell Mol Neurobiol 2020;40:667-74. [PMID: 32385549 DOI: 10.1007/s10571-020-00861-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
221 Palma G, Pasqua T, Silvestri G, Rocca C, Gualtieri P, Barbieri A, De Bartolo A, De Lorenzo A, Angelone T, Avolio E, Botti G. PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19. Front Immunol 2020;11:2094. [PMID: 32973818 DOI: 10.3389/fimmu.2020.02094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
222 Pazarlı AC, Ekiz T, İlik F. Coronavirus disease 2019 and obstructive sleep apnea syndrome. Sleep Breath 2021;25:371. [PMID: 32342265 DOI: 10.1007/s11325-020-02087-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
223 Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med 2020;9:E1753. [PMID: 32516940 DOI: 10.3390/jcm9061753] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 36.0] [Reference Citation Analysis]
224 Haybar H, Kazemnia K, Rahim F. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review. Jundishapur J Chronic Dis Care 2020;9. [DOI: 10.5812/jjcdc.103452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
225 Centurión OA. Cardiac injury and COVID-19 associated coagulopathy assessed by rotational thromboelastometry tests: Keep on searching for the right path. Advances in Medical Sciences 2022;67:139-41. [DOI: 10.1016/j.advms.2022.02.001] [Reference Citation Analysis]
226 Zhu F, Li W, Lin Q, Xu M, Du J, Li H. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Med Clin (Engl Ed) 2021;157:164-71. [PMID: 34458579 DOI: 10.1016/j.medcle.2021.01.014] [Reference Citation Analysis]
227 Istampoulouoglou I, Dimitriou G, Späni S, Christ A, Zimmermanns B, Koechlin S, Stoeckmann O, Winterhalder C, Marono D, Toma V, Leuppi-Taegtmeyer AB. Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract 2021;2021:e202118. [PMID: 34805376 DOI: 10.21542/gcsp.2021.18] [Reference Citation Analysis]
228 Ozturk S. COVID-19 and Stroke: A Neurological Perspective. In: Dehkharghani S, editor. Stroke. Exon Publications; 2021. pp. 171-8. [DOI: 10.36255/exonpublications.stroke.covid19.2021] [Reference Citation Analysis]
229 Abolfazli P, Aghajanzadeh T, Ghaderinasrabad M, Apue Nchama CN, Mokhlesi A, Talkhabi M. Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19. J Cell Commun Signal 2022. [PMID: 35525888 DOI: 10.1007/s12079-022-00678-y] [Reference Citation Analysis]
230 Ferrari F, Santos RD. Statins and COVID-19: To Suspend or Not to Suspend? That is the Question! Arq Bras Cardiol 2021;116:147-52. [PMID: 33566980 DOI: 10.36660/abc.20200949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
231 Tamura Y, Jee E, Kouzaki K, Kotani T, Nakazato K. Effects of endurance training on the expression of host proteins involved in SARS-CoV-2 cell entry in C57BL/6J mouse. Physiol Rep 2021;9:e15014. [PMID: 34523264 DOI: 10.14814/phy2.15014] [Reference Citation Analysis]
232 Sparks MA, South AM, Badley AD, Baker-Smith CM, Batlle D, Bozkurt B, Cattaneo R, Crowley SD, Dell'Italia LJ, Ford AL, Griendling K, Gurley SB, Kasner SE, Murray JA, Nath KA, Pfeffer MA, Rangaswami J, Taylor WR, Garovic VD. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension 2020;76:1350-67. [PMID: 32981369 DOI: 10.1161/HYPERTENSIONAHA.120.15948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
233 Zhu C, Sun B, Zhang X, Zhang B. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019. Front Pharmacol 2020;11:1327. [PMID: 32973534 DOI: 10.3389/fphar.2020.01327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
234 Akan S, Ediz C, Kızılkan YE, Alcin A, Tavukcu HH, Yilmaz O. COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy. Int J Clin Pract 2021;75:e13752. [PMID: 33064918 DOI: 10.1111/ijcp.13752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Kim J, Miyazaki K, Shah P, Kozai L, Kewcharoen J. Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis. Healthcare 2022;10:645. [DOI: 10.3390/healthcare10040645] [Reference Citation Analysis]
236 Sato K, Fujii K, Yamamoto N, Ichimura N, Yamaguchi S, Yamada H, Hibi H, Toyokuni S. Association of alcohol intake and female gender with high expression of TMPRSS2 in tongue as potential risk for SARS-CoV-2 infection. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.21-172] [Reference Citation Analysis]
237 Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res 2020;287:198108. [PMID: 32768490 DOI: 10.1016/j.virusres.2020.198108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
238 Bae JH, Choi SK, Kim NH, Lee J, Kim SG. Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study. Diabetes Metab J 2021;45:430-8. [PMID: 33611884 DOI: 10.4093/dmj.2020.0279] [Reference Citation Analysis]
239 Lima RS, Rocha LPC, Moreira PR. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19. Cell Biochem Funct 2021;39:713-26. [PMID: 34075603 DOI: 10.1002/cbf.3648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
240 Gimeno-Miguel A, Bliek-Bueno K, Poblador-Plou B, Carmona-Pírez J, Poncel-Falcó A, González-Rubio F, Ioakeim-Skoufa I, Pico-Soler V, Aza-Pascual-Salcedo M, Prados-Torres A, Gimeno-Feliu LA; PRECOVID Group. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study. PLoS One 2021;16:e0259822. [PMID: 34767594 DOI: 10.1371/journal.pone.0259822] [Reference Citation Analysis]
241 Radenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M. Cholesterol in Relation to COVID-19: Should We Care about It? J Clin Med 2020;9:E1909. [PMID: 32570882 DOI: 10.3390/jcm9061909] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 23.0] [Reference Citation Analysis]
242 Jamwal S, Gautam A, Elsworth J, Kumar M, Chawla R, Kumar P. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic. Life Sci 2020;257:118105. [PMID: 32687917 DOI: 10.1016/j.lfs.2020.118105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
243 Cagnacci A, Xholli A. Change in Covid-19 infection and mortality rates in postmenopausal women. Menopause 2021;28:573-5. [PMID: 33438894 DOI: 10.1097/GME.0000000000001731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
244 Umakanthan S, Chauhan A, Gupta MM, Sahu PK, Bukelo MM, Chattu VK. COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies. AIMS Public Health 2021;8:665-81. [PMID: 34786427 DOI: 10.3934/publichealth.2021053] [Reference Citation Analysis]
245 Sethumadhavan DV, Jabeena CA, Govindaraju G, Soman A, Rajavelu A. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives. Curr Res Microb Sci 2021;2:100079. [PMID: 34725650 DOI: 10.1016/j.crmicr.2021.100079] [Reference Citation Analysis]
246 Levy E, Delvin E, Marcil V, Spahis S. Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)? Am J Physiol Endocrinol Metab 2020;319:E689-708. [PMID: 32755302 DOI: 10.1152/ajpendo.00298.2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
247 Pericàs JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, Falces C, Marcos MA, Tuset M, Vilella A, Moreno A, Miro JM; Hospital Clínic Cardiovascular Infections Study Group. COVID-19: from epidemiology to treatment. Eur Heart J 2020;41:2092-112. [PMID: 32511724 DOI: 10.1093/eurheartj/ehaa462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 19.0] [Reference Citation Analysis]
248 Saeed O, Castagna F, Agalliu I, Xue X, Patel SR, Rochlani Y, Kataria R, Vukelic S, Sims DB, Alvarez C, Rivas-Lasarte M, Garcia MJ, Jorde UP. Statin Use and In-Hospital Mortality in Patients With Diabetes Mellitus and COVID-19. J Am Heart Assoc 2020;9:e018475. [PMID: 33092446 DOI: 10.1161/JAHA.120.018475] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
249 Paoli A, Gorini S, Caprio M. The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet? J Transl Med 2020;18:441. [PMID: 33218357 DOI: 10.1186/s12967-020-02600-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
250 Lehrer S, Rheinstein PH. Human Gene Sequences in SARS-CoV-2 and Other Viruses. In Vivo 2020;34:1633-6. [PMID: 32503822 DOI: 10.21873/invivo.11954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Zhu Z, Wang M, Lin W, Cai Q, Zhang L, Chen D, Liu F, Xiong X, Chu J, Peng J, Chen K. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Immun Inflamm Dis 2021. [PMID: 34405950 DOI: 10.1002/iid3.471] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
252 Liu F, Liu F, Wang L. COVID-19 and cardiovascular diseases. J Mol Cell Biol 2021;13:161-7. [PMID: 33226078 DOI: 10.1093/jmcb/mjaa064] [Reference Citation Analysis]
253 Oussalah A, Gleye S, Urmes IC, Laugel E, Barbé F, Orlowski S, Malaplate C, Aimone-Gastin I, Caillierez BM, Merten M, Jeannesson E, Kormann R, Olivier JL, Rodriguez-Guéant RM, Namour F, Bevilacqua S, Thilly N, Losser MR, Kimmoun A, Frimat L, Levy B, Gibot S, Schvoerer E, Guéant JL. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. EClinicalMedicine 2020;27:100554. [PMID: 32984786 DOI: 10.1016/j.eclinm.2020.100554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
254 Kotfis K, Lechowicz K, Drożdżal S, Niedźwiedzka-Rystwej P, Wojdacz TK, Grywalska E, Biernawska J, Wiśniewska M, Parczewski M. COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection. Pharmaceuticals (Basel) 2021;14:71. [PMID: 33477294 DOI: 10.3390/ph14010071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
255 Silva RN, Goulart CDL, Oliveira MR, Tacao GY, Back GD, Severin R, Faghy MA, Arena R, Borghi-Silva A. Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation. Expert Rev Respir Med 2021;15:1107-20. [PMID: 33606567 DOI: 10.1080/17476348.2021.1893169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
256 Martin JH, Head R. A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19. Br J Clin Pharmacol 2021;87:875-85. [PMID: 32959913 DOI: 10.1111/bcp.14551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
257 Darwesh AM, Bassiouni W, Sosnowski DK, Seubert JM. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol Ther 2021;219:107703. [PMID: 33031856 DOI: 10.1016/j.pharmthera.2020.107703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
258 Hussain M, Jabeen Q, Ahmad FU, Kashif-Ur-Rehman, Fatima M, Shaukat S, Majeed A, Barkat MQ, Wu X. COVID-19 and inhibitors of the renin-angiotensin-aldosterone system. Expert Rev Anti Infect Ther 2021;19:815-6. [PMID: 33198546 DOI: 10.1080/14787210.2021.1851197] [Reference Citation Analysis]
259 Pfeifer M, Ewig S, Voshaar T, Randerath W, Bauer T, Geiseler J, Dellweg D, Westhoff M, Windisch W, Schönhofer B, Kluge S, Lepper PM. [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society]. Pneumologie 2020;74:337-57. [PMID: 32323287 DOI: 10.1055/a-1157-9976] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
260 Rocha JLM, de Oliveira WCF, Noronha NC, Dos Santos NCD, Covas DT, Picanço-Castro V, Swiech K, Malmegrim KCR. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19. Stem Cell Rev Rep 2021;17:71-93. [PMID: 32895900 DOI: 10.1007/s12015-020-10032-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
261 Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, Lei F, Chen MM, Yang H, Bai L, Song X, Lin L, Xia M, Zhou F, Zhou J, She ZG, Zhu L, Ma X, Xu Q, Ye P, Chen G, Liu L, Mao W, Yan Y, Xiao B, Lu Z, Peng G, Liu M, Yang J, Yang L, Zhang C, Lu H, Xia X, Wang D, Liao X, Wei X, Zhang BH, Zhang X, Yang J, Zhao GN, Zhang P, Liu PP, Loomba R, Ji YX, Xia J, Wang Y, Cai J, Guo J, Li H. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metab. 2020;32:176-187.e4. [PMID: 32592657 DOI: 10.1016/j.cmet.2020.06.015] [Cited by in Crossref: 190] [Cited by in F6Publishing: 175] [Article Influence: 95.0] [Reference Citation Analysis]
262 Lehrer S, Rheinstein PH. Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2. In Vivo 2020;34:3023-6. [PMID: 32871846 DOI: 10.21873/invivo.12134] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
263 Liu X, Lou L, Zhou L. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection. Front Cardiovasc Med 2022;8:643958. [DOI: 10.3389/fcvm.2021.643958] [Reference Citation Analysis]
264 Djokovic N, Ruzic D, Djikic T, Cvijic S, Ignjatovic J, Ibric S, Baralic K, Buha Djordjevic A, Curcic M, Djukic-Cosic D, Nikolic K. An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease. Mol Inform 2021;40:e2000187. [PMID: 33787066 DOI: 10.1002/minf.202000187] [Reference Citation Analysis]
265 Yu Q, Wang Q, Zhang Y, Chen C, Ryu H, Park N, Baek JE, Li K, Wu Y, Li D, Xu J, Liu M, Yang JJ, Zhang C, Lu C, Zhang P, Li X, Chen B, Ebeid IA, Fensel J, Min C, Zhai Y, Song M, Ding Y, Bu Y. Analyzing knowledge entities about COVID-19 using entitymetrics. Scientometrics 2021;:1-19. [PMID: 33746309 DOI: 10.1007/s11192-021-03933-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
266 Poduri R, Joshi G, Jagadeesh G. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Cell Signal 2020;74:109721. [PMID: 32711111 DOI: 10.1016/j.cellsig.2020.109721] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
267 Cohen JB, South AM, Shaltout HA, Sinclair MR, Sparks MA. Renin-angiotensin system blockade in the COVID-19 pandemic. Clin Kidney J 2021;14:i48-59. [PMID: 33796285 DOI: 10.1093/ckj/sfab026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
268 Kannan S, Subbaram K, Ali S, Kannan H. Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARS-CoV-2, MERS-CoV, and Bat Coronavirus. J Pure Appl Microbiol 2020;14:757-63. [DOI: 10.22207/jpam.14.spl1.13] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
269 Mulinari Turin de Oliveira N, Fernandes da Silva Figueiredo I, Cristine Malaquias da Silva L, Sauruk da Silva K, Regis Bueno L, Barbosa da Luz B, Rita Corso C, de Paula Werner MF, Soares Fernandes E, Maria-Ferreira D. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality. Pathogens 2020;9:E817. [PMID: 33036180 DOI: 10.3390/pathogens9100817] [Reference Citation Analysis]
270 McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci 2020;21:E7189. [PMID: 33003377 DOI: 10.3390/ijms21197189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
271 Lim S, Shin SM, Nam GE, Jung CH, Koo BK. Proper Management of People with Obesity during the COVID-19 Pandemic. J Obes Metab Syndr 2020;29:84-98. [PMID: 32544885 DOI: 10.7570/jomes20056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
272 Mozaffari MS. Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19. J Pharmacol Exp Ther 2020;375:398-405. [PMID: 33008869 DOI: 10.1124/jpet.120.000243] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Rodrigues-Diez RR, Tejera-Muñoz A, Marquez-Exposito L, Rayego-Mateos S, Santos Sanchez L, Marchant V, Tejedor Santamaria L, Ramos AM, Ortiz A, Egido J, Ruiz-Ortega M. Statins: Could an old friend help in the fight against COVID-19? Br J Pharmacol 2020;177:4873-86. [PMID: 32562276 DOI: 10.1111/bph.15166] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
274 Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29:104949. [PMID: 32410807 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104949] [Cited by in Crossref: 154] [Cited by in F6Publishing: 133] [Article Influence: 77.0] [Reference Citation Analysis]
275 Khan SH, Zaidi SK. Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19. Drugs Ther Perspect 2020;:1-4. [PMID: 32837189 DOI: 10.1007/s40267-020-00750-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Alimohamadi Y, Sepandi M, Rashti R, Nezhad HS, Afrashteh S. COVID-19: Clinical features, case fatality, and the effect of symptoms on mortality in hospitalized cases in Iran. Journal of Taibah University Medical Sciences 2022. [DOI: 10.1016/j.jtumed.2022.04.010] [Reference Citation Analysis]
277 Gupta A, Al-Tamimi AO, Halwani R, Alsaidi H, Kannan M, Ahmad F. Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19. Exp Biol Med (Maywood) 2022;:15353702221091990. [PMID: 35466734 DOI: 10.1177/15353702221091990] [Reference Citation Analysis]
278 Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochem Pharmacol 2021;193:114812. [PMID: 34687672 DOI: 10.1016/j.bcp.2021.114812] [Reference Citation Analysis]
279 Dolan ME, Hill DP, Mukherjee G, McAndrews MS, Chesler EJ, Blake JA. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease. bioRxiv 2020:2020. [PMID: 32995795 DOI: 10.1101/2020.09.21.306720] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
280 Orlando V, Coscioni E, Guarino I, Mucherino S, Perrella A, Trama U, Limongelli G, Menditto E. Drug-utilisation profiles and COVID-19. Sci Rep 2021;11:8913. [PMID: 33903671 DOI: 10.1038/s41598-021-88398-y] [Reference Citation Analysis]
281 Marin T, Maxel X, Robin A, Stubbe L. Evidence-based assessment of potential therapeutic effects of adjunct osteopathic medicine for multidisciplinary care of acute and convalescent COVID-19 patients. Explore (NY) 2021;17:141-7. [PMID: 33158784 DOI: 10.1016/j.explore.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
282 Sansoè G, Aragno M, Wong F. COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy. Hepatology 2021;74:1074-80. [PMID: 33524188 DOI: 10.1002/hep.31728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Chappell MC. Commentary for "Endocrine significance of SARS-CoV-2's Reliance on ACE2". Endocrinology 2021;162:bqaa222. [PMID: 33269375 DOI: 10.1210/endocr/bqaa222] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Lionetti V, Bollini S, Coppini R, Gerbino A, Ghigo A, Iaccarino G, Madonna R, Mangiacapra F, Miragoli M, Moccia F, Munaron L, Pagliaro P, Parenti A, Pasqua T, Penna C, Quaini F, Rocca C, Samaja M, Sartiani L, Soda T, Tocchetti CG, Angelone T. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development. Pharmacol Res 2021;168:105581. [PMID: 33781873 DOI: 10.1016/j.phrs.2021.105581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
285 Berdina ON, Madaeva IM, Rychkova LV. [Novel coronavirus disease (COVID-19) and obstructive sleep apnea: age aspects of comorbidity]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:110-5. [PMID: 34078869 DOI: 10.17116/jnevro2021121402110] [Reference Citation Analysis]
286 Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, Venturini E, Iesu S, Virtuoso N, Strianese A, Ciccarelli M, Galasso G, Vecchione C. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art. Life (Basel) 2021;11:259. [PMID: 33801080 DOI: 10.3390/life11030259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
287 Ji H, de Souza AMA, Bajaj B, Zheng W, Wu X, Speth RC, Sandberg K. Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2. Hypertension 2020;76:478-87. [PMID: 32564694 DOI: 10.1161/HYPERTENSIONAHA.120.15276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
288 de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto AKLW, Barbosa BB. Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship. Rev Endocr Metab Disord 2022. [PMID: 35218458 DOI: 10.1007/s11154-022-09715-y] [Reference Citation Analysis]
289 Menon R, Otto EA, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppanna A, Luo J, Yang Y, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Harder JL, Mariani LH, Hodgin JB, Sexton JZ, Wobus CE, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M. SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease. medRxiv 2020:2020. [PMID: 32511461 DOI: 10.1101/2020.05.09.20096511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Akter F, Araf Y, Naser IB, Promon SK. Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury. Regen Ther 2021;18:447-56. [PMID: 34608441 DOI: 10.1016/j.reth.2021.09.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Mu HY, Lu YL, Hsiao TH, Huang JH. Microfluidic-based approaches for COVID-19 diagnosis. Biomicrofluidics 2020;14:061504. [PMID: 33343780 DOI: 10.1063/5.0031406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Seth R, McKinnon TAJ, Zhang XF. Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy. Am J Physiol Heart Circ Physiol 2022;322:H87-93. [PMID: 34890277 DOI: 10.1152/ajpheart.00204.2021] [Reference Citation Analysis]
293 Sica A, Casale D, Rossi G, Casale B, Ciccozzi M, Fasano M, Ciotti M, Sagnelli E, Papa A, Sagnelli C. The impact of the SARS-CoV-2 infection, with special reference to the hematological setting. J Med Virol 2021;93:223-33. [PMID: 32558961 DOI: 10.1002/jmv.26197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
294 Oh TK, Cho HW, Suh JW, Song IA. Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea. Yonsei Med J 2021;62:577-83. [PMID: 34164954 DOI: 10.3349/ymj.2021.62.7.577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev 2021;55:101382. [PMID: 32980614 DOI: 10.1016/j.smrv.2020.101382] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
296 Kaye AD, Spence AL, Mayerle M, Sardana N, Clay CM, Eng MR, Luedi MM, Carroll Turpin MA, Urman RD, Cornett EM. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes. Best Pract Res Clin Anaesthesiol 2021;35:437-48. [PMID: 34511231 DOI: 10.1016/j.bpa.2021.02.003] [Reference Citation Analysis]
297 Cohen JB, Hanff TC, Bress AP, South AM. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. Curr Hypertens Rep 2020;22:44. [PMID: 32591908 DOI: 10.1007/s11906-020-01048-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
298 Wiese O, Zemlin AE, Pillay TS. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2). J Clin Pathol 2021;74:285-90. [PMID: 32759311 DOI: 10.1136/jclinpath-2020-206954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
299 Loutradis C, Pitoulias AG, Pagkopoulou E, Pitoulias GA. Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients. Int Urol Nephrol 2021. [PMID: 34811606 DOI: 10.1007/s11255-021-03059-3] [Reference Citation Analysis]
300 Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020;106:1127-1131. [PMID: 32499236 DOI: 10.1136/heartjnl-2020-317186] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 26.5] [Reference Citation Analysis]
301 Abolaban FA, Djouider FM. Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development. Open Life Sci 2021;16:558-70. [PMID: 34131589 DOI: 10.1515/biol-2021-0051] [Reference Citation Analysis]
302 Paul RW, Omari A, Fliegel B, Bishop ME, Erickson BJ, Alberta FG. Effect of COVID-19 on Ulnar Collateral Ligament Reconstruction in Major League Baseball Pitchers. Orthop J Sports Med 2021;9:23259671211041359. [PMID: 34497864 DOI: 10.1177/23259671211041359] [Reference Citation Analysis]
303 Nizami DJ, Raman V, Paulose L, Hazari KS, Mallick AK. Role of laboratory biomarkers in assessing the severity of COVID-19 disease. A cross-sectional study. J Family Med Prim Care 2021;10:2209-15. [PMID: 34322414 DOI: 10.4103/jfmpc.jfmpc_145_21] [Reference Citation Analysis]
304 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
305 Hadi-Alijanvand H, Rouhani M. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes. J Proteome Res 2020;19:4609-23. [PMID: 32786692 DOI: 10.1021/acs.jproteome.0c00348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
306 Banu N, Panikar SS, Leal LR, Leal AR. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. Life Sci. 2020;256:117905. [PMID: 32504757 DOI: 10.1016/j.lfs.2020.117905] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 24.0] [Reference Citation Analysis]
307 Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc 2020;30:100631. [PMID: 32904969 DOI: 10.1016/j.ijcha.2020.100631] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
308 Acheampong DO, Barffour IK, Boye A, Aninagyei E, Ocansey S, Morna MT. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects. Biomed Pharmacother 2020;131:110748. [PMID: 33152916 DOI: 10.1016/j.biopha.2020.110748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
309 Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
310 Ashraf UM, Abokor AA, Edwards JM, Waigi EW, Royfman RS, Hasan SA, Smedlund KB, Hardy AMG, Chakravarti R, Koch LG. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics 2021;53:51-60. [PMID: 33275540 DOI: 10.1152/physiolgenomics.00087.2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
311 Scheen AJ. Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies. Diabetes Metab 2020;47:101220. [PMID: 33359486 DOI: 10.1016/j.diabet.2020.101220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
312 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
313 Sattar Y, Ullah W, Rauf H, Virk HUH, Yadav S, Chowdhury M, Connerney M, Mamtani S, Pahuja M, Patel RD, Mir T, Almas T, Moussa Pacha H, Chadi Alraies M. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. Int J Cardiol Heart Vasc 2020;29:100589. [PMID: 32724831 DOI: 10.1016/j.ijcha.2020.100589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
314 Santana FPR, Thevenard F, Gomes KS, Taguchi L, Câmara NOS, Stilhano RS, Ureshino RP, Prado CM, Lago JHG. New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother Res 2021. [PMID: 33928690 DOI: 10.1002/ptr.7131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
315 Shah P, Magee K, Buccellato KH, Ismond M, Watson J. Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study. Cardiovasc Diabetol 2022;21:24. [PMID: 35164745 DOI: 10.1186/s12933-022-01462-3] [Reference Citation Analysis]
316 Mao Y, Xu B, Guan W, Xu D, Li F, Ren R, Zhu X, Gao Y, Jiang L. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection. Front Endocrinol (Lausanne). 2020;11:593179. [PMID: 33488517 DOI: 10.3389/fendo.2020.593179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
317 Sarahian N, Saei Ghare Naz M, Ramezani Tehrani F. Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment? Endocrine 2021;72:356-7. [PMID: 33721205 DOI: 10.1007/s12020-021-02678-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Zhan Y, Ta W, Tang W, Hua R, Wang J, Wang C, Lu W. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. Drug Dev Res 2021. [PMID: 33847382 DOI: 10.1002/ddr.21815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
319 Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol 2020;11:1991. [PMID: 32903476 DOI: 10.3389/fimmu.2020.01991] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
320 Sheth A, Modi M, Dawson D, Dominic P. Prognostic value of cardiac biomarkers in COVID-19 infection. Sci Rep 2021;11:4930. [PMID: 33654230 DOI: 10.1038/s41598-021-84643-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
321 Martín Giménez VM, Ferder L, Inserra F, García J, Manucha W. Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19. Ther Adv Cardiovasc Dis 2020;14:1753944720977715. [PMID: 33283618 DOI: 10.1177/1753944720977715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
322 Moraes END, Viana LDG, Resende LMH, Vasconcellos LDS, Moura AS, Menezes A, Mansano NH, Rabelo R. COVID-19 nas instituições de longa permanência para idosos: estratégias de rastreamento laboratorial e prevenção da propagação da doença. Ciênc saúde coletiva 2020;25:3445-58. [DOI: 10.1590/1413-81232020259.20382020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
323 Tayebi khosroshahi H, Zarrintan A, Manaflouyan H, Rahmanpour D, Farashi E, Mousavi-aghdas SA, Mirza-aghazadeh-attari M, Tarzamni MK. COVID-19 in End-stage Renal Disease (ESRD) Patients Undergoing Hemodialysis: A Close Follow-up of Clinical Findings and Evolutions in Chest CT Imaging: A Retrospective Study. Nephro-Urol Mon 2021;In Press. [DOI: 10.5812/numonthly.118090] [Reference Citation Analysis]
324 Lozada-Martinez ID, Torres-Llinás DM, Moscote-Salazar LR. Myocardial lesion in patients with COVID-19: Not all is in the lung. J Taibah Univ Med Sci 2021;16:303-4. [PMID: 33584167 DOI: 10.1016/j.jtumed.2021.01.006] [Reference Citation Analysis]
325 Geisslinger F, Vollmar AM, Bartel K. Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa? Pharmaceuticals (Basel) 2020;13:E143. [PMID: 32640723 DOI: 10.3390/ph13070143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
326 Cîrstea AE, Buzulică RL, Pirici D, Ceauşu MC, Iman RV, Gheorghe OM, Neamţu SD, Stanca L, Ene R, Kumar-Singh S, Mogoantă L. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection. Rom J Morphol Embryol 2020;61:209-18. [PMID: 32747912 DOI: 10.47162/RJME.61.1.23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
327 Bánhegyi V, Enyedi A, Fülöp GÁ, Oláh A, Siket IM, Váradi C, Bottyán K, Lódi M, Csongrádi A, Umar AJ, Fagyas M, Czuriga D, Édes I, Pólos M, Merkely B, Csanádi Z, Papp Z, Szabó G, Radovits T, Takács I, Tóth A. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart. Cells 2021;10:1708. [PMID: 34359878 DOI: 10.3390/cells10071708] [Reference Citation Analysis]
328 Levine A, Sacktor N, Becker JT. Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research. J Neurovirol 2020;26:809-23. [PMID: 32880873 DOI: 10.1007/s13365-020-00897-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
329 Geraiely B, Samiei N, Sadeghipour P, Talasaz AH, Mortazavi SH, Sattarzadeh Badkoubeh R. COVID-19 and Cardiovascular Diseases. Adv Exp Med Biol 2021;1318:263-91. [PMID: 33973184 DOI: 10.1007/978-3-030-63761-3_16] [Reference Citation Analysis]
330 Miličić Stanić B, Maddox S, de Souza AMA, Wu X, Mehranfard D, Ji H, Speth RC, Sandberg K. Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2021;320:R925-37. [DOI: 10.1152/ajpregu.00356.2020] [Reference Citation Analysis]
331 Wang HY, Peng S, Ye Z, Li P, Li Q, Shi X, Zeng R, Yao Y, He F, Li J, Liu L, Ge S, Ke X, Zhou Z, Xu G, Zhao MH, Wang H, Zhang L, Dong E. Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension. Front Med 2021. [PMID: 34241787 DOI: 10.1007/s11684-021-0850-9] [Reference Citation Analysis]
332 Abbas R, El Naamani K, Sweid A, Schaefer JW, Bekelis K, Sourour N, Elhorany M, Pandey AS, Tjoumakaris S, Gooch MR, Herial NA, Rosenwasser RH, Jabbour P. Intracranial Hemorrhage in COVID-19 patients: A Case Series. World Neurosurg 2021:S1878-8750(21)01074-3. [PMID: 34298138 DOI: 10.1016/j.wneu.2021.07.067] [Reference Citation Analysis]
333 Baron MV, Santos MPD, Werle TM, Scherer GDLG, Santos MMD, Dominguez LML, Brandenburg C, Feltez G, Sampaio AR, de Mello Pinto MV, Carvalho S, Meyer PF, Picariello F, Pacheco EF, Reinheimer IC, Sancho AG, da Costa BEP. Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review. Medicine (Baltimore) 2022;101:e29058. [PMID: 35356924 DOI: 10.1097/MD.0000000000029058] [Reference Citation Analysis]
334 Knights H, Mayor N, Millar K, Cox M, Bunova E, Hughes M, Baker J, Mathew S, Russell-Jones D, Kotwica A. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clin Med (Lond) 2020;20:e148-53. [PMID: 32709637 DOI: 10.7861/clinmed.2020-0303] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
335 Singh A, Khanna P, Sarkar S. High-Flow Nasal Cannula, a Boon or a Bane for COVID-19 Patients? An Evidence-Based Review. Curr Anesthesiol Rep 2021;:1-6. [PMID: 33679254 DOI: 10.1007/s40140-021-00439-4] [Reference Citation Analysis]
336 Demirovic S, Lusic Kalcina L, Pavlinac Dodig I, Pecotic R, Valic M, Ivkovic N, Dogas Z. The COVID-19 Lockdown and CPAP Adherence: The More Vulnerable Ones Less Likely to Improve Adherence? Nat Sci Sleep 2021;13:1097-108. [PMID: 34290535 DOI: 10.2147/NSS.S310257] [Reference Citation Analysis]
337 Eun LY. Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children? Clin Exp Pediatr 2021;64:225-6. [PMID: 33677852 DOI: 10.3345/cep.2021.00031] [Reference Citation Analysis]
338 Canetta C, Accordino S, Buscarini E, Benelli G, La Piana G, Scartabellati A, Viganò G, Assandri R, Astengo A, Benzoni C, Gaudiano G, Cazzato D, Rossi DS, Usai S, Tramacere I, Lauria G. Syncope at SARS-CoV-2 onset. Auton Neurosci 2020;229:102734. [PMID: 32977101 DOI: 10.1016/j.autneu.2020.102734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
339 Cao Q, Lei H, Yang M, Wei L, Dong Y, Xu J, Nasser M, Liu M, Zhu P, Xu L, Zhao M. Impact of Cardiovascular Diseases on COVID-19: A Systematic Review. Med Sci Monit 2021;27:e930032. [PMID: 33820904 DOI: 10.12659/MSM.930032] [Reference Citation Analysis]
340 Henry BM, Benoit JL, Berger BA, Pulvino C, Lavie CJ, Lippi G, Benoit SW. Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7. J Med Virol 2021;93:678-80. [PMID: 32880990 DOI: 10.1002/jmv.26479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
341 Mancuso P, Gidaro A, Gregato G, Raveane A, Cremonesi P, Quarna J, Caccia S, Gusso L, Rusconi S, Giacomelli A, Cogliati C, Bertolini F. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J Thromb Haemost 2020;18:2744-50. [PMID: 32762140 DOI: 10.1111/jth.15044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
342 Novaes Matias J, Sorrentino dos Santos Campanari G, Achete de Souza G, Marinho Lima V, José Tofano R, Rucco Penteado Detregiachi C, M. Barbalho S; 1 Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho, 1001, Marília, São Paulo, Brazil, 2 Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marilia (UNIMAR), Avenue Hygino Muzzy Filho, 1001, Marília 17525-902, São Paulo, Brazil, 3 Department of Biochemistry and Nutrition, Faculty of Food Technology of Marília, Marília, São Paulo, Brazil. . AIMS Bioengineering 2020;7:242-53. [DOI: 10.3934/bioeng.2020021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
343 Cao Y, Zhang M, Guo Y, Zhang Y. The overlooked chamber in coronavirus disease 2019. ESC Heart Fail 2020. [PMID: 32964684 DOI: 10.1002/ehf2.12976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
344 Brown SA, Zaharova S, Mason P, Thompson J, Thapa B, Ishizawar D, Wilkes E, Ahmed G, Rubenstein J, Sanchez J, Joyce D, Kalyanaraman B, Widlansky M. Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology. Front Cardiovasc Med 2020;7:568720. [PMID: 33344513 DOI: 10.3389/fcvm.2020.568720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20:493-506. [PMID: 32720223 DOI: 10.1007/s10238-020-00648-x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 52.5] [Reference Citation Analysis]
346 Coles MJ, Masood M, Crowley MM, Hudgi A, Okereke C, Klein J. It Ain't Over 'Til It's Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility. Dig Dis Sci 2022. [PMID: 35357608 DOI: 10.1007/s10620-022-07480-1] [Reference Citation Analysis]
347 Castiglione GM, Zhou L, Xu Z, Neiman Z, Hung C, Duh EJ, Hejnol A. Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2. PLoS Biol 2021;19:e3001510. [DOI: 10.1371/journal.pbio.3001510] [Reference Citation Analysis]
348 Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021;12:693938. [PMID: 34790191 DOI: 10.3389/fimmu.2021.693938] [Reference Citation Analysis]
349 Gao F, Huang ZM. The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research. J Hepatol 2020;73:1568-9. [PMID: 32574579 DOI: 10.1016/j.jhep.2020.06.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
350 Heffernan DS, Evans HL, Huston JM, Claridge JA, Blake DP, May AK, Beilman GS, Barie PS, Kaplan LJ. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Surgical Infections 2020;21:301-8. [DOI: 10.1089/sur.2020.101] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 15.5] [Reference Citation Analysis]
351 Shen L, Qiu L, Wang L, Huang H, Liu D, Xiao Y, Liu Y, Jin J, Liu X, Wang DW, He B, Zhou N. Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease. Sci Rep 2021;11:23874. [PMID: 34903765 DOI: 10.1038/s41598-021-02534-2] [Reference Citation Analysis]
352 Bäuerle A, Teufel M, Musche V, Weismüller B, Kohler H, Hetkamp M, Dörrie N, Schweda A, Skoda EM. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf) 2020;42:672-8. [PMID: 32657323 DOI: 10.1093/pubmed/fdaa106] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 121.0] [Reference Citation Analysis]
353 Ramachandran P, Kathirvelu B, Chakraborti A, Gajendran M, Zhahid U, Ghanta S, Onukogu I, Narh JT, Wang JC, Anwer F. COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis. Cancer Control 2020;27:1073274820960457. [PMID: 33043705 DOI: 10.1177/1073274820960457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
354 Kell DB, Heyden EL, Pretorius E. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front Immunol 2020;11:1221. [PMID: 32574271 DOI: 10.3389/fimmu.2020.01221] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 32.5] [Reference Citation Analysis]
355 Hornick MG, Olson ME, Jadhav AL. SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies. Int J Neuropsychopharmacol 2021:pyab069. [PMID: 34648616 DOI: 10.1093/ijnp/pyab069] [Reference Citation Analysis]
356 Khaloo P, Shaqdan A, Ledesma PA, Uzomah UA, Jennifer Galvin, Ptaszek LM, Ruskin JN. Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19. Int J Cardiol 2021:S0167-5273(21)02032-5. [PMID: 34952038 DOI: 10.1016/j.ijcard.2021.12.029] [Reference Citation Analysis]